MedTrace Logo

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the MitraClip G4

NCT05455489 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 264

Last updated 2024-03-04

No results posted yet for this study

Summary

The aim of the GISE study is to confirm the MitraClip safety and improve the device effectiveness in a selected all comers ("more-comers") population with symptomatic severe mitral regurgitation undergoing/undergone Transcatheter Edge-to-Edge Repair (TEER) with MitraClip G4.

Conditions

  • Mitral Valve Regurgitation

Sponsors & Collaborators

  • University of Padova

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Fondazione GISE Onlus

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-25
Primary Completion
2029-08-01
Completion
2029-08-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05455489 on ClinicalTrials.gov